Clinical Trials Logo

Clinical Trial Summary

Currently, standard-of-care tractography is based on information obtained from diffusion tensor imaging (DTI). DTI is a diffusion magnetic resonance imaging (dMRI) technique that is routinely obtained on neurosurgical patients to assist in pre-operative planning. The primary objective of the proposed study is to determine the ability of msHARDI-based tractography to discern fibers in edematous brain regions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02559401
Study type Observational
Source Abramson Cancer Center at Penn Medicine
Contact
Status Completed
Phase
Start date June 2014
Completion date July 7, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT01254500 - To Investigate the Event Related Potentials (ERPs) of Patients With Brain Lesions N/A
Completed NCT01304576 - Orientation Agnosia: Clinical and Anatomical Study N/A
Completed NCT00907530 - Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain Phase 4
Terminated NCT02187822 - Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases Phase 1
Withdrawn NCT02328300 - FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions
Recruiting NCT01849549 - Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage N/A
Completed NCT03528200 - DYNA EMBOLIZATION - Pilot Study of IV Dyna CT and CBV Imaging Techniques N/A